Fetal size monitoring in women with gestational diabetes and normal glucose tolerance.
Kaat BeunenFrederik Van den AbbeelePaul Van CrombruggeJohan VerhaegheSofie VandeginsteHilde VerlaenenToon MaesEls DufraimontNele RoggenChristophe De BlockYves JacquemynFarah MekahliKatrien De ClippelAnnick Van den BruelAnne LoccufierAnnouschka LaenenRoland DevliegerChantal MathieuKatrien BenhalimaPublished in: Acta diabetologica (2024)
There were no differences in fetal size throughout pregnancy nor in LGA incidence between GDM and NGT women. EFW centile at 28-33 weeks correlated well with birthweight. This indicates that GDM treatment is effective and targeted ultrasound follow-up is useful. TRIAL REGISTRATION CLINICALTRIALS.GOV: NCT02036619. Registration date: January 15, 2014. https://clinicaltrials.gov/ct2/show/NCT02036619 .